Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

CACNA1E decreases the amount of CSRP3. 1 / 1

| 1

➶

reach

"Co-expression of Rpn13 150-407 and the MLPs alone led to a reduction in detectable amounts of OP91and OPG-TASK 85 (XREF_FIG A and B, lanes 1 and 4, see also accompanying graphs); suggesting that the Rpn13 150-407 -mediated displacement of endogenous SGTA (XREF_FIG Bii) reduces steady-state levels of MLP."

26169395

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...